美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ArQule

20.00

0.0000

成交量：- -

成交額：- -

市值：24.17億

市盈率：-58.12

高：20.00

開：20.00

低：20.00

收：20.00

52周最高：20.45

52周最低：3.15

股本：1.21億

流通股本：9,912.18萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.3441

每股收益(LYR):-0.1563

淨資產收益率：-32.12%

總資產收益率：-16.32%

市淨率：15.79

市盈率(LYR):-127.94

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

ArQule

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.arqule.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

<p>ARQULE公司是一家臨床生物技術公司，從事癌症治療的研究和藥物開發。本公司產品是ARQ197，一種受體酪氨酸激酶口服抑製劑，用於癌症治療。本公司對ARQ197進行商業使用認證，在美國，歐洲，南美和世界各地用於癌症治療。</p>

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARQL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARQL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQL\",,,,,undefined,":{"symbol":"ARQL","market":"US","secType":"STK","nameCN":"ArQule","latestPrice":20,"timestamp":1579122000000,"preClose":20,"halted":3,"volume":0,"delay":0,"floatShares":99121763,"shares":120873271,"eps":-0.344137,"marketStatus":"停牌","change":0,"latestTime":"01-15 16:00:00 EST","open":20,"high":20,"low":20,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.344137,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1766134800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":845438400000,"exchange":"NASDAQ","adjPreClose":20,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQL\",,,,,undefined,":{"symbol":"ARQL","floatShares":99121763,"roa":"-16.32%","roe":"-32.12%","lyrEps":-0.156328,"shares":120873271,"dividePrice":0,"high":20,"amplitude":0,"preClose":20,"low":20,"week52Low":3.15,"pbRate":"15.79","week52High":20.45,"institutionHeld":0.8268,"latestPrice":20,"eps":-0.344137,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.344137,"open":20,"prevYearClose":19.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARQL\",params:#limit:5,,,undefined,":[{"date":"2019-10-30","symbol":"ARQL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.09,"defaultRemindTime":1572422400000,"name":null,"time":"盤前","dateTimestamp":1572408000000,"actualEps":null},{"date":"2019-08-07","symbol":"ARQL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.09,"defaultRemindTime":1565164800000,"name":null,"time":"盤前","dateTimestamp":1565150400000,"actualEps":0.05},{"market":"US","date":"2019-05-01","symbol":"ARQL","fiscalQuarterEnding":"2019/03","expectedEps":-0.08,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556683200000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2019-03-07","symbol":"ARQL","fiscalQuarterEnding":"2018/12","expectedEps":-0.08,"name":null,"time":"盤前","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2018-10-31","symbol":"ARQL","fiscalQuarterEnding":"2018/09","expectedEps":-0.06,"name":null,"time":"盤前","type":"earning","dateTimestamp":1540958400000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARQL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARQL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.arqule.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"<p>ARQULE公司是一家臨床生物技術公司，從事癌症治療的研究和藥物開發。本公司產品是ARQ197，一種受體酪氨酸激酶口服抑製劑，用於癌症治療。本公司對ARQ197進行商業使用認證，在美國，歐洲，南美和世界各地用於癌症治療。</p>","exchange":"NASDAQ","name":"ArQule","nameEN":"Arqule"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARQL\",market:\"US\",,,undefined,":null}}